DIARY - Global Company News Preview - Week ending Sept 25
Sept. 17 (Reuters) - Here are the top 5 global company news stories and scheduled events for the week ending Sept 25, 2009. The diary is arranged by industry sector. It's compiled by the Reuters company news editors for news planning.
For major company news diaries, please see:
S&P 500 earnings - weekly [SP500/WK]
Non S&P 500 earnings - weekly [NSP500/WK]
The Day Ahead - US equities [DAY/US]
Western European company events [WEU/EQUITY]
Asia company earnings [ASIA/EQTY]
TOP STORIES IN THE WEEK ENDING SEPT 25 * IPO craze: USA to post best week in almost 2 years, Wynn's Asia IPO road show * TMT: RIMM Q2, Google CEO interview, ALU CEO appearance & Tokyo Game Show * Focus on banker pay & bonuses @ G-20 in Pittsburgh * Health: Euro cancer meet, Dendreon analyst day & EU OKs swine flu vaccines * Kraft-Cadbury: Irene's secret overtures to Todd
SCHEDULED EVENTS IN THE WEEK ENDING SEPT 25 (Dates in parenthesis)
FINANCIAL
- (i)-banking: SocGen CEO presser (22); Close Bros (23); Shanghai Bank conference (25) with HSBC, BoC & BoCom,
- Private banking: CS private banking day (22) IRS amnesty for offshore tax cheats ends (23); USA government lawyer in UBS case speech (25)
- IPO craze: Pricings of REITs Colony &n Apollo (22); A123 & Julius baer's Artio; Wynn HK IPO road show (23); Select Medical, Shanda Games & REIT Foursquare (24)
- Trading: Nasdaq CEO speech (22); FIA Equity Options conference on algo trading in NY (22-23), with CBOE, ISE, SEC, CFTC & FINRA
- Funds: Alliance Trust, Pacific Assets H1 (21); Asia SuperReturn conference (22-24) with Carlyle & KKR; Liontrust trade (23); Julius Baer strategy briefing (25); Possible annual report of GMC.
TMT
- Top stories: RIMM Q2, Insider interview Google CEO interview & ALU's Verwaayen speech (23); Tokyo Game Show with Sony, Nintendo & MSFT - Software: Progress Q3 (22); Auto Zone Q4, Red Hat Q2 (23); TIBCO Q3, Saba Q1 (24)
- Other: Brocade analyst meet (22); HP analyst meet (24) HEALTH
- Cancer: Euro cancer meet in Berlin with new data on Amgen;s denosumab & Imclone/Lilly/Merck Erbitux (20-24), Dendreon analyst day (24)
- Approvals/studies: FDA advisory panel on Neuromed Exalgo (23); EU expert panel recommends swine flu vaccines
RESOURCES
- Potash story package (22-25)
- Ag: ConAgra Foods Q1 (22), General Mills Q1 (23), McCormick Q3 (24); Tate & Lyle trade (25)
ECONOMY
- Housing/construction : Lennar Q3 (21); Lowe's analyst meet (24); KB Home Q3 (25)
- Leisure: Carnival Q3 (22); Mitchells trade, Vail Resorts Q4 (24)
- Retail: Bed Bath & Beyond Q2 (23); H&M Q3, Rite Aid Q2 (24)
- Transport: Interview AutoNation (21)
- Aerospace: Possible Pentagon bidding document for $35 bln aerial tanker contract
----------------------------------------------------------
** This diary is filed every Thursday
For questions and feedback, please
e-mail:jack.reerink@thomsonreuters.com
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.


Follow Reuters